Cargando…

POS-013 THROMBOTIC MICROANGIOPATHY AFTER COVID-19: LACK OF EVIDENCE OF COMPLEMENT ACTIVATION? A CASE REPORT

Detalles Bibliográficos
Autores principales:	Vu, A., Ngo, V., Bui, T., Tran, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213007/ http://dx.doi.org/10.1016/j.ekir.2022.04.031

Ejemplares similares

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Thrombotic microangiopathies assessment: mind the complement
por: Blasco, Miquel, et al.
Publicado: (2020)

Postsurgical Thrombotic Microangiopathy and Deregulated Complement
por: van Herpt, Thijs T. W., et al.
Publicado: (2022)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Complement, thrombotic microangiopathy and disseminated intravascular coagulation
por: Kurosawa, Shinichiro, et al.
Publicado: (2014)

Complement Mediated Endothelial Damage in Thrombotic Microangiopathies
por: Blasco, Miquel, et al.
Publicado: (2022)

POS-172 RENAL THROMBOTIC MICROANGIOPATHY , ANCA VASCULITIS AND COVID 19 INFECTION: AN INTRIGUING ASSOCIATION
por: Chargui, S., et al.
Publicado: (2021)

Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report
por: Bruno, Valentina, et al.
Publicado: (2023)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
por: Gavriilaki, Eleni, et al.
Publicado: (2019)

Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangiopathies
por: Hofer, Johannes, et al.
Publicado: (2014)

The potential role of complements in cocaine-induced thrombotic microangiopathy
por: Dejman, Adriana, et al.
Publicado: (2018)

Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation
por: Acosta-Medina, Aldo A., et al.
Publicado: (2022)

Evidence for secondary thrombotic microangiopathy in COVID-19
por: Sweeney, Joseph M., et al.
Publicado: (2020)

No Evidence for Classic Thrombotic Microangiopathy in COVID-19
por: Falter, Tanja, et al.
Publicado: (2021)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea
por: Brocklebank, Vicky, et al.
Publicado: (2017)

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy
por: Novikov, Pavel, et al.
Publicado: (2016)

Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
por: Chonat, Satheesh, et al.
Publicado: (2020)

The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation
por: Timmermans, Sjoerd A. M. E. G., et al.
Publicado: (2021)

Peering into the darkness of drug-induced thrombotic microangiopathy: complement, are you in there?
por: Sabulski, Anthony, et al.
Publicado: (2023)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

COVID-19 and thrombotic microangiopathies
por: Tiwari, Nishant R., et al.
Publicado: (2021)

Complement C5 inhibition reverses bleomycin-induced thrombotic microangiopathy
por: Salhi, Sofiane, et al.
Publicado: (2020)

Complement inhibitor eculizumab in thrombotic microangiopathy: Single‐center case series
por: Vitkauskaitė, Monika, et al.
Publicado: (2022)

P1642: OUTCOMES IN HOSPITALIZED PATIENTS WITH COMPLEMENT MEDIATED THROMBOTIC MICROANGIOPATHY
por: Logothetis, C., et al.
Publicado: (2022)

Acute Pancreatitis: A Rare Cause of Complement-Mediated Thrombotic Microangiopathy
por: Livingston, Jonathan, et al.
Publicado: (2023)

Complement inhibition for the treatment of COVID-19 triggered thrombotic microangiopathy with cardiac failure: a case report
por: Utebay, Didar, et al.
Publicado: (2021)

Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19
por: Wang, Xin, et al.
Publicado: (2020)

POS-013 FACTORS ASSOCIATED WITH ACUTE KIDNEY INJURY IN CRITICALLY ILL PATIENTS WITH COVID-19
por: de Fátima Alencar Miranda, A., et al.
Publicado: (2021)

Tacrolimus: Thrombotic microangiopathy: case report
Publicado: (2021)

Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report
por: Torres, Everardo Arias, et al.
Publicado: (2021)

Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
por: Chen, Fei-Fei, et al.
Publicado: (2023)

Complement-Mediated Thrombotic Microangiopathy and Spontaneous Splenic Rupture Associated With Cytomegalovirus Infection
por: Shabir, Sadia, et al.
Publicado: (2023)

Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
por: Hasbal, Nuri Baris
Publicado: (2020)

Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination
por: Aigner, Christof, et al.
Publicado: (2023)

The role of ADAMTS‐13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies
por: Phillips, E. H., et al.
Publicado: (2016)

Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls
por: Gavriilaki, Eleni, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vttd4208h2rpkh5qg3rsdctg0m